ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. 原著論文

Fusion protein based on Grb2-SH2 domain for cancer therapy

https://repo.qst.go.jp/records/46009
https://repo.qst.go.jp/records/46009
c053bc49-7e63-4a6f-8a55-e266a49c3431
Item type 学術雑誌論文 / Journal Article(1)
公開日 2011-03-01
タイトル
タイトル Fusion protein based on Grb2-SH2 domain for cancer therapy
言語
言語 eng
資源タイプ
資源タイプ識別子 http://purl.org/coar/resource_type/c_6501
資源タイプ journal article
アクセス権
アクセス権 metadata only access
アクセス権URI http://purl.org/coar/access_right/c_14cb
著者 Saito, Yuriko

× Saito, Yuriko

WEKO 457879

Saito, Yuriko

Search repository
Furukawa, Takako

× Furukawa, Takako

WEKO 457880

Furukawa, Takako

Search repository
Arano, Yasushi

× Arano, Yasushi

WEKO 457881

Arano, Yasushi

Search repository
Fujibayashi, Yasuhisa

× Fujibayashi, Yasuhisa

WEKO 457882

Fujibayashi, Yasuhisa

Search repository
Saga, Tsuneo

× Saga, Tsuneo

WEKO 457883

Saga, Tsuneo

Search repository
齋藤 有里子

× 齋藤 有里子

WEKO 457884

en 齋藤 有里子

Search repository
古川 高子

× 古川 高子

WEKO 457885

en 古川 高子

Search repository
荒野 泰

× 荒野 泰

WEKO 457886

en 荒野 泰

Search repository
藤林 康久

× 藤林 康久

WEKO 457887

en 藤林 康久

Search repository
佐賀 恒夫

× 佐賀 恒夫

WEKO 457888

en 佐賀 恒夫

Search repository
抄録
内容記述タイプ Abstract
内容記述 Epidermal growth factor receptor (EGFR) is one of the very attractive targets for cancer therapy. In this study, we generated fusion proteins containing one or two Src-homology 2 (SH2) domains of growth factor receptor bound protein 2 (Grb2), which bind to phosphorylated EGFR, added with HIV-1 transactivating transcription for cell membrane penetration (termed TSF and TSSF, respectively). We examined if they can interfere Grb2-mediated signaling pathway and suppress tumor growth as expected from the lack of SH3 domain, which is necessary to intermediate EGFR–Grb2 cell signaling, in the fusion proteins. The transduction efficiency of TSSF was similar to that of TSF, but the binding activity of TSSF to EGFR was higher than that of TSF. Treatment of EGFR-overexpressing cells showed that TSSF decreased p42-ERK phosphorylation, while TSF did not. Both the proteins delayed cell growth but did not induce cell death in culture. TSSF also significantly suppressed tumor growth in vivo under consecutive administration. In conclusion, TSSF showed an ability to inhibit EGFR–Grb2 signaling and could have a potential to treat EGFR-activated cancer.
書誌情報 Biochemical and Biophysical Research Communications

巻 399, 号 2, p. 262-267, 発行日 2010-07
ISSN
収録物識別子タイプ ISSN
収録物識別子 0006-291X
DOI
識別子タイプ DOI
関連識別子 10.1016/j.bbrc.2010.07.066
戻る
0
views
See details
Views

Versions

Ver.1 2023-05-15 23:56:58.074025
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3